Insider Transactions in Q3 2025 at Jazz Pharmaceuticals PLC (JAZZ)
Insider Transaction List (Q3 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 05
2025
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
577
-1.39%
|
$66,932
$116.1 P/Share
|
Aug 01
2025
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.23%
|
$113,000
$113.21 P/Share
|
Jul 01
2025
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.11%
|
$107,000
$107.63 P/Share
|